|

Lorlatinib with chemotherapy1 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LOBRENA

Pipeline

Early 1: 1

Top Sponsors

  • Nationwide Children's Hospital1

Indications

  • Infant Type Hemispheric Glioma1
  • WHO Grade IV Glioma1
  • WHO Grade III Glioma1
  • Diffuse Midline Glioma, H3K27-altered1
  • Anaplastic Astrocytoma1

Aurora, Colorado1 trial

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Children's Hospital Colorado

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.